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Hereditary spherocytosis is a genetically determined abnormality of red blood cells. It is likely that a defect of intracellular glycolysis results in the formation of spherical cells (spherocytes) which have a reduced life span and exhibit increased osmotic fragility in hypotonic saline solutions, increased susceptibility to mechanical trauma, and spontaneous lysis on incubation. Lysis is markedly reduced by the presence of added glucose (Dacie, 1963) . Splenectomy usually results in clinical cure, although haematological signs of the disease may persist; for example, while osmotic fragility improves, it rarely returns to normal, and mechanical fragility of both fresh and incubated blood remains significantly abnormal.
The imposition of cardiopulmonary bypass on normal subjects is associated with some destruction of the formed elements of blood. Haemolysis occurs, and plasma haemoglobin levels rise at a rate which is seldom less than 0-25 mg per minute, consequent upon the trauma of bubble oxygenation, roller pumps and cardiotomy suction. Haemolysis of this degree is seldom important as the kidney is well able to tolerate plasma haemoglobin levels of up to 250 mg per 100 ml, and oxygen carrying capacity is not seriously deranged. However, the altered robustness of the red cells in a patient with hereditary spherocytosis may preclude an operation with cardiopulmonary bypass on the ground of excessive haemolysis. There are no available published reports of an operation with cardiopulmonary bypass in a patient with hereditary spherocytosis. We report a reconstructive operation on the mitral valve in such a patient, with particular reference to the conduct of cardiopulmonary bypass. The patient was re-admitted a year later with a history of increasing dyspnoea, in cardiac failure, and with the signs of mitral regurgitation. The form of management recommended was mitral valve repair. Haematological investigation at this time showed the haemoglobin to be 13 g%, PCV 36%, MCH 36%, WBC 10,000 per c.mm, and reticulocytes 0 5%. A blood smear showed evidence of haemolytic anaemia; serum bilirubin was 0-6%; osmotic fragility of the red blood cells in serial dilutions of saline showed fragility little different from that before splenectomy.
In view of the uncertain tolerance of the abnormal red cell corpuscles in hereditary spherocy,tosis to cardiopulmonary bypass, it was thought necessary to assess the response of a sample of the patient's blood to an experiment designed to simulate those aspects of cardiopulmonary bypass most damaging to blood. In the unit to which she was admitted bubble oxygenators of the disposable Travenol variety are used. The size of the bag selected allows an output of arterialized blood calculated on the basis of 2'5 litres per square metre of body surface area. Pumps are adjusted so that both rollers are just short of occlusive. The priming volume of Travenol bags vanes with size, but, in general, when primed with a liquid other than blood, priming volume approximates calculated blood volume and, consequently, during bypass a 50% reduction in the haematocrit is expected.
In the experimental bypass a 'one-litre flow' Travenol bag primed with 450 ml of Ringer lactate and 30 mg of heparin was used. The circuit was similar to that which would be employed for the intended surgical operation. Priming fluid was drawn from the helix reservoir of the bag by the 'arterial' roller pump and circulated through a standard Sarnes heat exchange unit maintained at 37°C. The fluid was then pumped through a narrow metal cannula with an internal bore considered close to the size of the femoral arterial cannula which would be used for the ultimate operative procedure. The circuit was 131 D. G. Moyes, M. A. Rogers, and A. J. Coleman 
